Concepedia

Ryo Saji

RS

Statistics

Publications

5

Citations

156

H-Index

5

Active since

2020

Affiliations

Yokohama City University(Current)

Yokohama City University Medical Center

National Institute of Infectious Diseases

Life Science Institute

Kanto Chemical (Japan)

Ryo Saji is an author at Yokohama City University specializing in covid-19, immunology, and medicine.

ORCID

Top concepts

Publications per year

2020–2021

5

Publications

5

Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach

Yayoi Kimura, Yusuke Nakai, Jihye Shin et al. · Scientific Reports · 2021 · 64 citations · Full text

, , +28

Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles

Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Norihisa Ohtake et al. · Journal of Molecular Cell Biology · 2020 · 34 citations · Full text

, , +11

Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19

Fumihiro Ogawa, Yasufumi Oi, Kento Nakajima et al. · Thrombosis Journal · 2021 · 29 citations · Full text

Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19

Ryo Saji, Mototsugu Nishii, Kazuya Sakai et al. · PLoS ONE · 2021 · 19 citations · Full text

Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles

Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Norihisa Ohtake et al. · 2020 · 10 citations · Full text

, , +11

1–5 of 5